These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14767717)

  • 21. Melanin and neuromelanin binding of drugs and chemicals: toxicological implications.
    Karlsson O; Lindquist NG
    Arch Toxicol; 2016 Aug; 90(8):1883-91. PubMed ID: 27311820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanin affinity of manganese.
    Lydén A; Larsson BS; Lindquist NG
    Acta Pharmacol Toxicol (Copenh); 1984 Aug; 55(2):133-8. PubMed ID: 6437141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromelanin and Parkinson's disease.
    Marsden CD
    J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB; Ben-Shachar D; Riederer P
    J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine melanin-loaded PC12 cells: a model for studies on pigmented neurons.
    Ostergren A; Svensson AL; Lindquist NG; Brittebo EB
    Pigment Cell Res; 2005 Aug; 18(4):306-14. PubMed ID: 16029423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromelanin and its possible protective and destructive properties.
    Lindquist NG; Larsson BS; Lydén-Sokolowski A
    Pigment Cell Res; 1987; 1(3):133-6. PubMed ID: 3334086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanin affinity and its possible role in neurodegeneration.
    Karlsson O; Lindquist NG
    J Neural Transm (Vienna); 2013 Dec; 120(12):1623-30. PubMed ID: 23821370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The melanin binding of bisoprolol and its toxicological relevance.
    Steiner K; Bühring KU; Merck E
    Lens Eye Toxic Res; 1990; 7(3-4):319-33. PubMed ID: 1983104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Competition-Binding Assay to Determine Binding Affinity of Molecules to Neuromelanin via Fluorescence Spectroscopy.
    Fink J; Pathak H; Smith J; Achat-Mendes C; Haining RL
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31072013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,9-Dimethyl-beta-carbolinium, a neurotoxin occurring in human brain, is a potent inducer of apoptosis as 1-methyl-4-phenylpyridinium.
    Pavlovic S; Schulze G; Wernicke C; Bonnet R; Gille G; Badiali L; Kaminska A; Lorenc-Koci E; Ossowska K; Rommelspacher H
    Neuroscience; 2006; 139(4):1525-37. PubMed ID: 16517085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pheomelanin as a binding site for drugs and chemicals.
    Mårs U; Larsson BS
    Pigment Cell Res; 1999 Aug; 12(4):266-74. PubMed ID: 10454295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma harman and norharman in Parkinson's disease.
    Kuhn W; Müller T; Grosse H; Rommelspacher H
    J Neural Transm Suppl; 1995; 46():291-5. PubMed ID: 8821066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical review of the function of neuromelanin and an attempt to provide a unified theory.
    Nicolaus BJ
    Med Hypotheses; 2005; 65(4):791-6. PubMed ID: 15949901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel S-adenosylmethionine-dependent indole-N-methylation of beta-carbolines in brain particulate fractions.
    Matsubara K; Neafsey EJ; Collins MA
    J Neurochem; 1992 Aug; 59(2):511-8. PubMed ID: 1629724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
    Collins MA; Neafsey EJ; Cheng BY; Hurley-Gius K; Ung-Chhun NA; Pronger DA; Christensen MA; Hurley-Gius D
    Adv Neurol; 1987; 45():179-82. PubMed ID: 3493625
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta-carbolines, psychoactive compounds in the mammalian body. Part I: Occurrence, origin and metabolism.
    Airaksinen MM; Kari I
    Med Biol; 1981 Feb; 59(1):21-34. PubMed ID: 7022042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Catecholaminergic neurons of mammalian brain and neuromelanin].
    Sukhorukova EG; Alekseeva OS; Korzhevskii DE
    Zh Evol Biokhim Fiziol; 2014; 50(5):336-42. PubMed ID: 25786315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and occurrence of beta-carboline alkaloids in raisins and inhibition of monoamine oxidase (MAO).
    Herraiz T
    J Agric Food Chem; 2007 Oct; 55(21):8534-40. PubMed ID: 17883257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.